Lupin's Generic Entresto Approved by USFDA, Set to Rival Novartis' Bestseller Farhat Nasim29 Jan 2025 8:04 PM ISTMumbai: In a fresh challenge to Novartis' blockbuster heart failure drug Entresto, Indian generics maker Lupin has received approval from the U.S....
US Appeals Court decision favors MSN Pharma in Novartis heart drug Entresto generic dispute Ruchika Sharma9 Dec 2024 10:00 AM ISTNovartis suffered a legal setback on Wednesday as the company failed to persuade a U.S. appeals court to halt MSN Pharmaceuticals' proposed generic of...
Entresto: Novartis loses initial bid to block generic of blockbuster heart drug Ruchika Sharma14 Aug 2024 11:30 AM ISTLondon: Novartis, a leading pharmaceutical company, has failed in its attempt to convince a federal court to block MSN Pharmaceuticals, a generic...
MSN Lab Gets CDSCO Panel Nod To Manufacture, Market Vigabatrin Powder for Oral Solution Dr. Divya Colin28 Jun 2023 6:00 PM ISTNew Delhi: The drug major MSN Laboratories has got approval from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
MSN to launch generic anti-COVID pill Molnupiravir Medical Dialogues Bureau8 Jan 2022 9:45 AM ISTNew Delhi: Pharmaceuticals firm MSN Group on Thursday said it will launch its generic anti-COVID-19 pill Molnupiravir under the brand 'Molulow' in...
MSN Pharma concludes USFDA audit with zero observations Ruchika Sharma22 Dec 2021 12:09 PM ISTHyderabad: MSN Pharmaceuticals Inc. (MSNPI), a wholly-owned subsidiary of MSN Group of Companies, based out of Piscataway, New Jersey, USA has...
